NO178718C - Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa - Google Patents

Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa

Info

Publication number
NO178718C
NO178718C NO864971A NO864971A NO178718C NO 178718 C NO178718 C NO 178718C NO 864971 A NO864971 A NO 864971A NO 864971 A NO864971 A NO 864971A NO 178718 C NO178718 C NO 178718C
Authority
NO
Norway
Prior art keywords
vitro
immortalized
kits
preparation
equipment
Prior art date
Application number
NO864971A
Other languages
English (en)
Other versions
NO864971L (no
NO178718B (no
NO864971D0 (no
Inventor
Anthony W Siadak
Mae J Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO864971D0 publication Critical patent/NO864971D0/no
Publication of NO864971L publication Critical patent/NO864971L/no
Publication of NO178718B publication Critical patent/NO178718B/no
Publication of NO178718C publication Critical patent/NO178718C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO864971A 1985-12-10 1986-12-10 Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa NO178718C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US93117986A 1986-11-24 1986-11-24

Publications (4)

Publication Number Publication Date
NO864971D0 NO864971D0 (no) 1986-12-10
NO864971L NO864971L (no) 1987-06-11
NO178718B NO178718B (no) 1996-02-12
NO178718C true NO178718C (no) 1996-05-22

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864971A NO178718C (no) 1985-12-10 1986-12-10 Preparat for anvendelse in vitro, udödelig, transformert cellelinje og humant, monoklonalt antistoff, samt sett eller utstyr for anvendelse ved påvisning in vitro av tilstedeværelse av Pseudomonas aeruginosa

Country Status (21)

Country Link
US (4) US5378812A (no)
JP (1) JPH07116237B2 (no)
KR (1) KR910008361B1 (no)
CN (1) CN86108380A (no)
AT (1) AT400441B (no)
BE (1) BE905890A (no)
CH (1) CH677362A5 (no)
DE (1) DE3642095C2 (no)
DK (1) DK594586A (no)
FI (1) FI86377C (no)
FR (1) FR2593826B1 (no)
GB (1) GB2185266B (no)
HU (1) HUT41836A (no)
IE (1) IE59741B1 (no)
IT (1) IT1199735B (no)
LU (1) LU86711A1 (no)
NL (1) NL8603132A (no)
NO (1) NO178718C (no)
NZ (1) NZ218499A (no)
PT (1) PT83894B (no)
SE (1) SE468831B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
JP2725041B2 (ja) * 1986-12-15 1998-03-09 三井東圧化学株式会社 ヒトモノクローナル抗体とそれを有効成分とする感染症の予防、治療剤
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
AU619672B2 (en) * 1989-03-20 1992-01-30 Mitsui Toatsu Chemicals Inc. Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH0329196A (ja) * 1989-05-09 1991-02-07 Advanced Micro Devicds Inc センス増幅器
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
WO2003063693A2 (en) * 2002-01-31 2003-08-07 Expressive Constructs, Inc. Method for detecting microorganisms
EP1506217A4 (en) * 2002-05-29 2006-04-12 Jackson H M Found Military Med METHOD FOR IDENTIFYING GENOMIC AND PROTEOMIC BIOMARKERS FOR CYSTIC FIBROSIS, BIOMARKER COMPRISING ARRANGEMENTS AND METHOD FOR APPLYING THE ARRANGEMENTS
BR0215954A (pt) * 2002-11-26 2005-09-13 Uc Tech Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
AU2004225575B2 (en) * 2003-01-31 2008-02-21 Ethicon, Inc. Method for detecting escherichia coli
CA2557612C (en) 2003-11-03 2014-06-17 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
EP1690875A1 (en) * 2005-02-14 2006-08-16 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype
JP5324438B2 (ja) * 2006-05-01 2013-10-23 バイオネス ニューロモジュレイション リミテッド 改良型機能的電気刺激システム
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
US20130022603A1 (en) * 2010-02-18 2013-01-24 Symphogen A/S Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
EP0168422A1 (en) * 1983-12-12 1986-01-22 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies

Also Published As

Publication number Publication date
NO864971L (no) 1987-06-11
SE8605295D0 (sv) 1986-12-10
SE8605295L (sv) 1987-06-11
FI86377C (fi) 1992-08-25
GB2185266A (en) 1987-07-15
NO178718B (no) 1996-02-12
DE3642095A1 (de) 1987-07-02
IE59741B1 (en) 1994-03-23
NO864971D0 (no) 1986-12-10
GB2185266B (en) 1990-09-05
HUT41836A (en) 1987-05-28
DK594586A (da) 1987-06-11
SE468831B (sv) 1993-03-29
BE905890A (fr) 1987-06-10
IE863230L (en) 1987-06-10
CN86108380A (zh) 1987-10-28
FI865027A7 (fi) 1987-06-11
JPH07116237B2 (ja) 1995-12-13
JPS62187417A (ja) 1987-08-15
FR2593826B1 (fr) 1990-11-16
US5662905A (en) 1997-09-02
NZ218499A (en) 1990-04-26
DE3642095C2 (de) 1998-10-01
LU86711A1 (fr) 1988-07-14
KR870005648A (ko) 1987-07-06
KR910008361B1 (ko) 1991-10-12
US5378812A (en) 1995-01-03
NL8603132A (nl) 1987-07-01
ATA328286A (de) 1995-05-15
FI865027A0 (fi) 1986-12-10
US5628996A (en) 1997-05-13
FI86377B (fi) 1992-05-15
GB8629540D0 (en) 1987-01-21
CH677362A5 (no) 1991-05-15
DK594586D0 (da) 1986-12-10
IT8622630A0 (it) 1986-12-10
AT400441B (de) 1995-12-27
US5627067A (en) 1997-05-06
IT1199735B (it) 1988-12-30
PT83894A (en) 1987-01-01
PT83894B (pt) 1989-07-31
FR2593826A1 (fr) 1987-08-07

Similar Documents

Publication Publication Date Title
AU7566991A (en) Monoclonal antibody and immunoconjugates for the treatment and detection of b cell disorders
IT1225944B (it) Saggi immunometrici e di inibizione con l&#39;impiego di anticorpi monoclonici
AU5443286A (en) Test kit for determining the presence of organic materials and method of utilizing same
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
DK583688A (da) Markeringskit med glasperler og fremgangsmaade til fremstilling af perlerne
IT1158864B (it) Procedimento per la rivelazione di fughe su pezzi in prova quali fusti recipienti o simili e relativo dispositivo di rivelazione
ATA425180A (de) Einrichtung zur metallspiegel-kryofixation sowie zur nachfolgenden kryopraeparation biologischer objekte
DE3477845D1 (en) Lewis blood group phenotype assay
DK108780A (da) Fremgangsmaade til fremstilling af urinstofderivater disses anvendelse samt mellemprodukter til anvendelse ved fremstillingen
BR8101452A (pt) Valvula de derivacao com placa corredica e processo de fabricacao da valvula de derivacao com placa corredica
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
DK166780C (da) Optisk aktivt borankompleks og fremgangsmaade til fremstilling af optisk aktive alkoholderivater under anvendelse heraf
IT1133058B (it) Procedimento e dispositivo per la preconcentrazione dei reagenti immunologici
DK478785D0 (da) Fremgangsmaade til maaling af signalkomposanternes egenskaber i evideosignal samt apparat til udoevelse af fremgangsmaaden
DK231280A (da) Apparat til brug ved udkravning af roer
DK563988D0 (da) Roer eller ledning og fremgangsmaade til fremstilling af et saadant roer eller en saadan ledning
FI891816A7 (fi) Pseudomonas aeruginosa-vastainen monoklonaalinen vasta-aine, sen valmistus ja käyttö
IT1131217B (it) Vetro cavo e procedimento per la sua realizzazione
IT1183809B (it) Procedimento per l&#39;analisi qualitativa e quantitativa di interferone epsilon
AU5639590A (en) Process and device for determining the concentration of an antibody-antigen pair
DK602785A (da) Fremgangsmaade til fremstilling af 3-substituerede n-pyridylindoler samt mellemprodukter til anvendelse ved fremgangsmaaden
DK329880A (da) 3-substituerede bicycliske azetidinonderivater samt deres fremstilling og anvendelse
AU526550B2 (en) Amplifier and symmetrical bridge
NO179410C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive monobenzofyriner og anvendelse av disse
IT8122505V0 (it) Cerniera per ante in vetro di facile e rapida applicazione.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2001